G Square Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, G Square Capital has invested in 1 company.

G Square Capital’s most common sectors for investment arehealthcare services (60%) and medical products (15%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (50%) and growth capital (25%). In total, G Square Capital has invested in 10 different countries.

In the last 3 years, G Square Capital has exited 1 company. The Firm’s most common exit type is trade sale (75%). G Square Capital’s largest (disclosed) exit occurred in 2017 when it sold Mikeva Oy for $169M.

Subscribe to Mergr to view G Square Capital’s full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity24
    • M&A Buy Activity20
    • M&A Sell Activity4
  • Total Sectors Invested 7
  • Total Countries Invested 10
  • M&A Buy/Sell Connections 7
  • M&A Advisors 1

G Square Capital

G Square Healthcare Private Equity LLP

24 Savile Row, Mayfair,
London, W1S 2ES
United Kingdom
+44 (0) 20 3757 0160
www.gsquarecapital.com
contact@gsquarecapital.com

G Square Capital is a specialist private equity group focused on acquiring and/or providing growth capital to mid-cap healthcare companies with an enterprise value up to €200 million. G Square primarily looks for opportunities in Europe and specifically targets healthcare services (private hospitals, nursing homes, diagnostic labs, imaging centers), services to the healthcare industry, medical technology providers, and pharmaceuticals. G Square was formed in 2008 and is based in London.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Nordic, Middle East

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 30 60
Enterprise Value - 200
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.6/yr) # 17 2 - 1 - - 20
Sell (0.2/yr) # 3 - - - 1 - 4
vol $169M $169M
  24

Most Recent M&A

Company Date Value Type
Duomed Belgium NV 2024-04-16 - Trade Sale
Aartselaar, Belgium · www.duomed.com
Mayden House Ltd. 2023-11-07 - Growth Capital
Bath, United Kingdom · www.mayden.co.uk
AM Healthcare Group 2021-01-01 - Buyout (LBO, MBO, MBI)
Oxfordshire, United Kingdom · www.amhealthcaregroup.com
Community Health and Eyecare Ltd. 2021-01-01 - Buyout (LBO, MBO, MBI)
Preston, United Kingdom · www.chec.uk
Femi Premium Ltd. 2020-08-16 - Stake Purchase
Holon, Israel · www.femi.com
Zahnarztzentrum. ch AG 2020-05-26 - Trade Sale
Winterthur, Switzerland · www.zahnarztzentrum.ch
Diagnostic Healthcare Ltd. 2020-01-15 - Buyout (LBO, MBO, MBI)
Manchester, United Kingdom · www.diagnostichealthcareltd.com
Chrysalis Finance Ltd. 2019-04-08 - Buyout (LBO, MBO, MBI)
Brentwood, United Kingdom · www.together.dental
Medicharme S.A.S. 2018-01-01 - Buyout (LBO, MBO, MBI)
Versailles, France · www.medicharme.fr
Mikeva Oy 2017-05-31 169M EUR Trade Sale
Vantaa, Finland · www.mikeva.fi
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 7 (50%) - 12 (60%) -
Medical Products 2 (14%) - 3 (15%) -
Consumer Services 1 (7%) - 1 (5%) -
Education 1 (7%) - 1 (5%) -
Manufacturing 1 (7%) - 1 (5%) -
Retail 1 (7%) - 1 (5%) -
Software 1 (7%) - 1 (5%) -
Total 14 - 20 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United Kingdom 8 (57%) - 8 (40%) -
Germany 1 (7%) - 3 (15%) -
France 2 (14%) - 2 (10%) -
Israel 1 (7%) - 1 (5%) -
Netherlands 1 (7%) - 1 (5%) -
Norway 1 (7%) - 1 (5%) -
Spain - - 1 (5%) -
Belgium - - 1 (5%) -
Finland - - 1 (5%) -
Switzerland - - 1 (5%) -
Domestic 8 (57%) - 8 (40%) -
Cross-border 6 (43%) - 12 (60%) -
Total 14 - 20 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 9 (64%) - 10 (50%) -
Growth Capital 2 (14%) - 5 (25%) -
Secondary Buyout 2 (14%) - 4 (20%) -
Stake Purchase 1 (7%) - 1 (5%) -
Total 14 - 20 -

Exits by Deal Type

Type Total # Value
Trade Sale 2 (50%) -
Trade Sale - Public Company 1 (25%) 169M (100%)
Secondary Sale 1 (25%) -
Total 4 $169M

Top M&A Advisors

Financial Deals
Altium Capital Ltd.
1

Deal Values

sell # Total
$100M to $1B 1 $169M
TOTAL $169M
Largest Mikeva Oy
$169M (2017-05-31)

M&A Connections

Deals
Acquired from
Investor(s)
20%
4 (20%)
Exited to
Investor(s)
25%
1 (25%)
Strategic(s)
75%
3 (75%)

FAQ

When was G Square Capital founded?

G Square Capital was founded in 2008.

What type of investor is G Square Capital?

G Square Capital is a private equity firm.

Where is G Square Capital headquartered?

G Square Capital is headquartered in London, United Kingdom.

How much capital does G Square Capital have under management?

G Square Capital has 2.0B EUR under management.

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.